Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer

Abstract

The newly constructed support vector machine signature precisely and powerfully predicted relapse and survival in patients with stage I-II pancreatic ductal adenocarcinoma after R0 resection.